IZP 94005

Drug Profile

IZP 94005

Alternative Names: Contignasterol; Pneumocort

Latest Information Update: 02 Aug 2004

Price : $50

At a glance

  • Originator Inflazyme Pharmaceuticals
  • Class Antiallergics; Antiasthmatics; Antihistamines; Antirheumatics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 02 Aug 2004 Discontinued - Preclinical for Asthma in United Kingdom (unspecified route)
  • 02 Aug 2004 Discontinued - Preclinical for Asthma in Canada (unspecified route)
  • 11 Jun 1999 No-Development-Reported for Asthma in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top